CERE

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CERE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/12	20 : 30	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 30	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/06	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 33	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 32	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 27	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 26	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 25	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	22 : 24	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	21 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/08/01	21 : 23	PR Newswire (US)	AbbVie Completes Acquisition of Cerevel Therapeutics	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/05/09	05 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/04/18	19 : 30	GlobeNewswire Inc.	Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/02/28	06 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/02/17	06 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/02/09	23 : 00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/02/09	09 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/01/24	22 : 30	PR Newswire (US)	Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/01/24	07 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/01/24	07 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/01/24	07 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc
2024/01/24	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERE	Cerevel Therapeutics Holdings Inc